Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAS3681 |
Trade Name | |
Synonyms | TAS 3681 |
Drug Descriptions |
TAS3681 is an androgen receptor (AR) inhibitor that induces cell death in AR-positive prostate cancer cells, potentially resulting in antitumor activity (J Clin Oncol 33, 2015 (suppl 7; abstr 266); J Clin Oncol 39, no. 15_suppl (May 20, 2021) 5031-5031). |
DrugClasses | Hormone - Anti-androgens 54 |
CAS Registry Number | NA |
NCIT ID | C137818 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TAS3681 | TAS3681 | 0 | 1 |